Single pulse protoacoustic range verification using a clinical synchrocyclotron

Phys Med Biol. 2023 Jan 12. doi: 10.1088/1361-6560/acb2ae. Online ahead of print.ABSTRACTOBJECTIVE: Proton therapy as the next generation radiation-based cancer therapy offers dominant advantages over conventional radiation therapy due to the utilization of the Bragg peak; however, range uncertainty in beam delivery substantially mitigates the advantages of proton therapy. This work reports using protoacoustic measurements to determine the location of proton Bragg peak deposition within a water phantom in real time during beam delivery.APPROACH: In protoacoustics, proton beams have a definitive range, depositing a majority of the dose at the Bragg peak; this dose is then converted to heat. The resulting thermoelastic expansion generates a 3D acoustic wave, which can be detected by acoustic detectors to localize the Bragg peak.MAIN RESULTS: Protoacoustic measurements were performed with a synchrocyclotron proton machine over the exhaustive energy range from 45.5MeV to 227.15MeV in clinic. It was found that the amplitude of the acoustic waves is proportional to proton dose deposition, and therefore encodes dosimetric information. With the guidance of protoacoustics, each individual proton beam (7pC/pulse) can be directly visualized with sub-millimeter (<0.7 mm) resolution using single beam pulse for the first time.SIGNIFICANCE: The ability to localize the Bragg peak in real-time and obtain acoustic signals proportional to dose within tumors could enable precision proton ther...
Source: Physics in Medicine and Biology - Category: Physics Authors: Source Type: research